|4Mar 26, 7:27 PM ET

CAREMARK RX INC 4

4 · CAREMARK RX INC · Filed Mar 26, 2007

Insider Transaction Report

Form 4
Period: 2007-03-22
KARRO BRADLEY S
EVP-Info Tech & Medicare
Transactions
  • Disposition to Issuer

    Stock Option

    2007-03-22180,0000 total
    Exercise: $32.03From: 2005-05-10Exp: 2014-05-10Common Stock, par value $.001 (180,000 underlying)
  • Disposition to Issuer

    Stock Option

    2007-03-2275,0000 total
    Exercise: $50.84From: 2007-03-01Exp: 2016-03-01Common Stock, par value $.001 (75,000 underlying)
  • Disposition to Issuer

    Stock Option

    2007-03-2250,0000 total
    Exercise: $13.21From: 2001-11-07Exp: 2011-11-07Common Stock, par value $.001 (50,000 underlying)
  • Disposition to Issuer

    Common Stock, par value $.001

    2007-03-226,5950 total
  • Disposition to Issuer

    Stock Option

    2007-03-2212,0000 total
    Exercise: $18.35From: 2003-04-02Exp: 2013-04-02Common Stock, par value $.001 (12,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to a merger agreement between issuer and CVS Corporation at the rate of 1.67 shares of CVS/Caremark Corporation common stock for each share of issuer stock. All issuer shares held by Reporting Person were disposed.
  • [F2]Issuer options are being replaced in the merger with CVS/Caremark Corporation options exercisable for CVS/Caremark Corporation common stock. The number of CVS/Caremark Corporation common shares and the exercise price of the CVS/Caremark Corporation replacement option will be computed using a formula that will result in the Reporting Person receiving an intrinsic value in the CVS/Caremark Corporation replacement option that will be approximately equal to the intrinsic value of the issuer options valued immediately prior to the merger.

Documents

1 file
  • 4
    rrd152405.xmlPrimary

    CVS MERGER